Federated Hermes’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,577
| Closed | -$45.9K | – | 2181 |
|
|
2024
Q4 | $45.9K | Sell |
1,577
-25,557
| -94% | -$743K | ﹤0.01% | 1689 |
|
|
2024
Q3 | $1.25M | Buy |
27,134
+23,871
| +732% | +$1.1M | ﹤0.01% | 1056 |
|
|
2024
Q2 | $133K | Sell |
3,263
-82
| -2% | -$3.35K | ﹤0.01% | 1537 |
|
|
2024
Q1 | $85.4K | Buy |
+3,345
| New | +$85.4K | ﹤0.01% | 1583 |
|
|
2023
Q4 | – | Sell |
-942
| Closed | -$6.01K | – | 2183 |
|
|
2023
Q3 | $6.01K | Buy |
+942
| New | +$6.01K | ﹤0.01% | 1868 |
|
|
2023
Q2 | – | Sell |
-2,363,600
| Closed | -$36.3M | – | 2212 |
|
|
2023
Q1 | $36.3M | Hold |
2,363,600
| – | – | 0.09% | 261 |
|
|
2022
Q4 | $52.4M | Sell |
2,363,600
-114,400
| -5% | -$2.54M | 0.15% | 178 |
|
|
2022
Q3 | $40.5M | Buy |
2,478,000
+3,500
| +0.1% | +$57.2K | 0.12% | 218 |
|
|
2022
Q2 | $36M | Hold |
2,474,500
| – | – | 0.1% | 256 |
|
|
2022
Q1 | $45.7M | Hold |
2,474,500
| – | – | 0.1% | 244 |
|
|
2021
Q4 | $58.8M | Sell |
2,474,500
-1,400
| -0.1% | -$33.3K | 0.11% | 240 |
|
|
2021
Q3 | $61M | Buy |
2,475,900
+504,984
| +26% | +$12.4M | 0.12% | 238 |
|
|
2021
Q2 | $48.7M | Buy |
1,970,916
+170,482
| +9% | +$4.21M | 0.09% | 285 |
|
|
2021
Q1 | $39.3M | Buy |
1,800,434
+368,834
| +26% | +$8.04M | 0.08% | 328 |
|
|
2020
Q4 | $36.5M | Buy |
1,431,600
+158,000
| +12% | +$4.03M | 0.07% | 311 |
|
|
2020
Q3 | $35.9M | Buy |
1,273,600
+902,681
| +243% | +$25.4M | 0.08% | 275 |
|
|
2020
Q2 | $10.5M | Buy |
+370,919
| New | +$10.5M | 0.03% | 526 |
|